Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

TRNS US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

TRNS US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Transcat Inc(TRNS US)

$89.52+1.601.82%Ext:$94.05+4.535.07%(Pre-Market · 09:10:09 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Transcat Inc(TRNS US)

$89.52+1.601.82%Ext:$94.05+4.535.07%(Pre-Market · 09:10:09 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials & Metrics

FinancialsChartingShort InterestEmployees

Transcat Inc — Company Profile

Transcat, Inc. is a provider of accredited calibration and laboratory instrument services, and a value-added distributor of professional grade test, measurement, and control instrumentation. The company operates through two segments, Service and Distribution, and focuses on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, and medical device businesses.

Sector
Information Technology
Industry
Electronic Equipment, Instruments & Components
Exchange
UQ
CEO
Jaime A. Irick
Headquarters
Rochester, NY, US
IPO Date
Dec 5, 1977
Employees
1,413
Website
www.transcat.com

Key Metrics

Price
$90.39
Market Cap
$846.03M
Revenue (TTM)
$73.35M
Net Income (TTM)
$3.69M
EPS (TTM)
0.41
P/E (TTM)
128.60
P/B (TTM)
2.81
Dividend Yield
0.00%
ROE (TTM)
1.79%
ROA (TTM)
1.12%
Operating Margin
4.00%
Beta
0.90

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Transcat, Inc. is a provider of accredited calibration and laboratory instrument services, and a value-added distributor of professional grade test, measurement, and control instrumentation. The company operates through two segments, Service and Distribution, and focuses on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, and medical device businesses.

Website
www.transcat.com
Location
Rochester, NY, US
Phone585 352 7777
Employees1,413
CEOJaime A. Irick
Sector
Information Technology
Industry
Electronic Equipment, Instruments & Components
IPO DateDec 5, 1977

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(1.3K)

Expand
  • 10-QQ2ended 26 Sept 20263 Nov
  • 8-KResults of Operations and Financial Condition3 Nov
  • SC 13G/ATRANSCAT INC30 Oct
  • 4Mecca Robert10 Sep
  • 4Langston Cynthia10 Sep
  • 4Kaniki Mbago M.10 Sep
  • 4Haseley Gary J.10 Sep
  • 4Gillette Christopher P.10 Sep
  • 4Dominach Oksana S.10 Sep
  • 4DePerrior Dawn10 Sep
  • 4Cairns Craig D.10 Sep
  • 8-KSubmission of Matters to a Vote of Security Holders10 Sep
  • S-3ASRAutomatic shelf registration statement (S-3)4 Sep
  • 4Dominach Oksana S.3 Sep
  • 144Dominach Oksana S.3 Sep
  • 4Dominach Oksana S.17 Aug
  • 4Gillette Christopher P.12 Aug
  • 4Cairns Craig D.10 Aug
  • 10-QQ1ended 27 Jun 20264 Aug
  • 8-KResults of Operations and Financial Condition4 Aug

News

  • Transcat, Inc. (TRNS) Q2 2027 Earnings Call Transcript02:35AM
  • Transcat (TRNS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates3 Nov
  • Transcat, Inc. (TRNS) Q2 Earnings and Revenues Top Estimates3 Nov
  • Transcat Q2 Earnings Call Highlights3 Nov
  • Transcat Reports Strong Fiscal Second Quarter 2027 Financial Results with Double-Digit Service Organic Revenue* Growth and Significant Service Gross Margin Expansion3 Nov
  • Is the Options Market Predicting a Spike in Transcat Stock?2 Nov
  • Transcat to Attend Upcoming Investor Conferences in November2 Nov
  • Conestoga Micro Cap Composite: Q3 2026 Leaders, Laggards, Buys And Sells29 Oct
  • Can Transcat (TRNS) Keep the Earnings Surprise Streak Alive?29 Oct
  • Transcat to Host Second Quarter Fiscal Year 2027 Conference Call and Webcast on Tuesday, November 3, 2026 at 4:30 p.m. Eastern Time20 Oct
  • Is Transcat Inc (TRNS) a Bargain After 3.0% Drop? GF Value Says Undervalued23 Sep
  • Transcat Holdings: Recent Share Price Weakness Provides A Solid Entry Point16 Sep
  • Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical31 Aug
  • Transcat to Participate in Jefferies, Lake Street and D.A. Davidson Investor Conferences in September27 Aug
  • Dimensional Fund Advisors LP Grows Position in Transcat, Inc. $TRNS8 Aug
  • Transcat, Inc. (TRNS) Q1 2027 Earnings Call Transcript5 Aug
  • Transcat Q1 Earnings Call Highlights4 Aug
  • Transcat, Inc. (TRNS) Q1 Earnings and Revenues Top Estimates4 Aug
  • Transcat Reports Strong Fiscal First Quarter 2027 Financial Results with Double-Digit Service Organic Revenue* Growth and Service Gross Margin Expansion4 Aug

Mentions in Filings

  • … s also served as Executive Chairman since August 2023. Prior to his appointment as President and Chief Executive Officer of Lakeland, Mr. Jenkins was the General Counsel and Vice President of Corporate Development for <strong>Transcat, Inc.</strong> (Nasdaq: TRNS), a provider of calibration, repair, inspection and laboratory services, where he served as Transcat’s chief risk officer and advised management and the board of directors over matters of corporate gover …
    BirchBioMed Inc.Transcat Inc·S-1/A - Registration statement (general form, amendment)·Q4 26·9 Oct
  • #\*Titan International, Inc. 195,756 1,867,512 \*Titan Machinery, Inc. 75,804 1,233,331 Toro Co. (The) 207,339 18,971,519 \*<strong>Transcat</strong>, Inc. 27,596 1,664,315 \*Trex Co., Inc. 265,532 10,998,335 TriNet Group, Inc. 126,724 7,760,578 Trinity Industries, Inc. 287,475 8,262,031 \*TrueBlue, Inc. 96,809 518,896
    Dimensional ETF TrustTranscat Inc·NPORT-EX - NT NPORT-P - Notification of late filing (portfolio holdings)·Q1 26·13 Aug
  • … s also served as Executive Chairman since August 2023. Prior to his appointment as President and Chief Executive Officer of Lakeland, Mr. Jenkins was the General Counsel and Vice President of Corporate Development for <strong>Transcat, Inc.</strong> (Nasdaq: TRNS), a provider of calibration, repair, inspection and laboratory services, where he served as Transcat’s chief risk officer and advised management and the board of directors over matters of corporate gover …
    BirchBioMed Inc.Transcat Inc·S-1 - Registration statement (general form)·Q3 26·12 Aug
  • … ties. 1.Ameresco, Inc. 2.Columbus McKinnon Corporation 3.Concrete Pumping Holdings, Inc. 4.Custom Truck One Source, Inc. 5.Energy Recovery, Inc. 6.Enerpac Tool Group Corp. 7.Global Industrial Company 8.Insteel Industries Inc. 9.Karat Packaging Inc. 10.Limbach Holdings, Inc. 11.Matrix Service Company 12.McGrath RentCorp 13.Myers Industries, Inc. 14.Standex International Corporation 15.<strong>Transcat, Inc.</strong> 16.WillScot Holdings Corporation
    NPK International Inc.Transcat Inc·EX-10.2 - 10-Q - Quarterly report Q2·Q2 26·30 Jul
  • … s also served as Executive Chairman since August 2023. Prior to his appointment as President and Chief Executive Officer of Lakeland, Mr. Jenkins was the General Counsel and Vice President of Corporate Development for <strong>Transcat, Inc.</strong> (Nasdaq: TRNS), a provider of calibration, repair, inspection and laboratory services, where he served as Transcat’s chief risk officer and advised management and the board of directors over matters of corporate gover …
    BirchBioMed Inc.Transcat Inc·DRS/A - Draft registration statement (amendment)·Q3 26·1 Jul
  • … oceeds and meaningfully strengthening the Company's balance sheet. • Appointed Lee D. Rudow to its Board of Directors, effective April 9, 2026. Mr. Rudow previously served as Chief Executive Officer of Nasdaq-listed <strong>Transcat, Inc.</strong> --- Fiscal 2027 First Quarter Financial Highlights • Net sales were $47.4 million in Q1 FY27, compared to $46.7 million in Q1 FY26, an increase of $0.7 million or 1.4%, driven by the Fire Service product line and …
    LAKELAND INDUSTRIES INCTranscat Inc·EX-99.1 - 8-K - Results of Operations and Financial Condition·Q2 27·9 Jun

Key Stats

Trading

Px/Chg 1D$90.39 / +0.23%
Avg Volume155.82K
Beta0.90
Mkt Cap846.03M
FD Mkt Cap798.20M

Float

Shrs Out/Float9.36M / 9.14M
Short Float0.06%
Days to Cover2.87
Stock Repurchased$469.00K

Current Valuation

EV969.98M
EV/EBITDA23.90
EV/Sales2.92
P/B2.81
P/S2.54
FCF Yield0.31%
ROE1.79%
ROA1.12%
Current Ratio2.33

Estimates

P/E128.60
Est P/E0.00
Est EPS0.51
Est PEG0.00

Valuation

Metric5Yr AvgAug '22Aug '23Aug '24Aug '25Oct '26
PRICE-BASED RATIOS
Price / Earnings131.1044.6761.8266.6447.86434.53
Price / Sales4.162.482.873.502.509.47
Price / Book Value4.365.906.634.042.422.81
Price / Free Cash Flow111.3868.0887.6647.0326.94327.16
ENTERPRISE VALUE METRICS
Enterprise Value784.1564.6723.6911.3751.0970.0
Enterprise Value / Sales4.592.753.143.512.7010.86
Enterprise Value / EBITDA36.7823.9626.9426.9519.9286.14
Enterprise Value / EBIT78.7940.3345.5044.9539.27223.91

Financials

Full Financials
Millions USD5Yr CAGR (%)Mar '22Mar '23Mar '24Mar '25Mar '26
INCOME STATEMENT
Revenue12.8%205.0230.6259.5278.4331.9
Gross Income16.7%58.468.483.889.5108.3
EBITDA13.2%23.626.933.837.738.8
EBIT-2.6%14.015.920.319.112.6
Net Income-17.1%11.410.713.614.55.4
EPS (Diluted)-21.5%1.501.401.631.570.57
BALANCE SHEET
Cash & ST Inv37.2%1.41.535.21.54.9
Total Assets28.2%177.8195.7287.6385.2480.5
Total Liabilities18.4%91.696.162.498.4179.9
Total Shareholder Equity36.7%86.299.6225.2286.9300.6
CASH FLOW
Net Operating Cash Flow18.6%17.617.032.639.034.9
Cap Ex10.8%-10.2-9.4-13.3-13.2-15.3
Free Cash Flow27.2%7.57.519.325.819.6

Enterprise Value Bridge

Millions USD23 Oct '26
Price (As of 23 Oct '26)81.92
Basic Shares9.36
Market Cap766.8
Diluted Shares9.00
Fully Diluted Shares Outstanding9.00
Fully Diluted Market Cap737.3
+Consolidated Debt128.9
−In-the-Money Convertible Debt—
+Capital Leases29.0
+Operating Leases—
−Cash & Equivalents-4.9
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value890.7

Segment data

Revenue

by Products and services

  • Service65%
  • Distribution Service35%

Revenue

by Geography

  • United States95%
  • Canada5%

Related companies

Danaher Corp /DE/

DHR US

Teradyne, Inc

TER US

Keysight Technologies Inc.

KEYS US

Ametek Inc/

AME US

Compagnie De Saint Gobain

CODYY US

Roper Technologies Inc

ROP US

UltraTech Cement Ltd

UTCEM IB

China Jushi Co., Ltd.

600176 CG

Veralto Corp

VLTO US

Kingspan Group plc

KGSPY US

Mks Inc

MKSI US

Fortive Corp

FTV US

Transcat Inc — Company Profile

Transcat, Inc. is a provider of accredited calibration and laboratory instrument services, and a value-added distributor of professional grade test, measurement, and control instrumentation. The company operates through two segments, Service and Distribution, and focuses on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, and medical device businesses.

Sector
Information Technology
Industry
Electronic Equipment, Instruments & Components
Exchange
UQ
CEO
Jaime A. Irick
Headquarters
Rochester, NY, US
IPO Date
Dec 5, 1977
Employees
1,413
Website
www.transcat.com

Key Metrics

Price
$90.39
Market Cap
$846.03M
Revenue (TTM)
$73.35M
Net Income (TTM)
$3.69M
EPS (TTM)
0.41
P/E (TTM)
128.60
P/B (TTM)
2.81
Dividend Yield
0.00%
ROE (TTM)
1.79%
ROA (TTM)
1.12%
Operating Margin
4.00%
Beta
0.90

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Transcat, Inc. is a provider of accredited calibration and laboratory instrument services, and a value-added distributor of professional grade test, measurement, and control instrumentation. The company operates through two segments, Service and Distribution, and focuses on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, and medical device businesses.

Website
www.transcat.com
Location
Rochester, NY, US
Phone585 352 7777
Employees1,413
CEOJaime A. Irick
Sector
Information Technology
Industry
Electronic Equipment, Instruments & Components
IPO DateDec 5, 1977

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(1.3K)

Expand
  • 10-QQ2ended 26 Sept 20263 Nov
  • 8-KResults of Operations and Financial Condition3 Nov
  • SC 13G/ATRANSCAT INC30 Oct
  • 4Mecca Robert10 Sep
  • 4Langston Cynthia10 Sep
  • 4Kaniki Mbago M.10 Sep
  • 4Haseley Gary J.10 Sep
  • 4Gillette Christopher P.10 Sep
  • 4Dominach Oksana S.10 Sep
  • 4DePerrior Dawn10 Sep
  • 4Cairns Craig D.10 Sep
  • 8-KSubmission of Matters to a Vote of Security Holders10 Sep
  • S-3ASRAutomatic shelf registration statement (S-3)4 Sep
  • 4Dominach Oksana S.3 Sep
  • 144Dominach Oksana S.3 Sep
  • 4Dominach Oksana S.17 Aug
  • 4Gillette Christopher P.12 Aug
  • 4Cairns Craig D.10 Aug
  • 10-QQ1ended 27 Jun 20264 Aug
  • 8-KResults of Operations and Financial Condition4 Aug

News

  • Transcat, Inc. (TRNS) Q2 2027 Earnings Call Transcript02:35AM
  • Transcat (TRNS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates3 Nov
  • Transcat, Inc. (TRNS) Q2 Earnings and Revenues Top Estimates3 Nov
  • Transcat Q2 Earnings Call Highlights3 Nov
  • Transcat Reports Strong Fiscal Second Quarter 2027 Financial Results with Double-Digit Service Organic Revenue* Growth and Significant Service Gross Margin Expansion3 Nov
  • Is the Options Market Predicting a Spike in Transcat Stock?2 Nov
  • Transcat to Attend Upcoming Investor Conferences in November2 Nov
  • Conestoga Micro Cap Composite: Q3 2026 Leaders, Laggards, Buys And Sells29 Oct
  • Can Transcat (TRNS) Keep the Earnings Surprise Streak Alive?29 Oct
  • Transcat to Host Second Quarter Fiscal Year 2027 Conference Call and Webcast on Tuesday, November 3, 2026 at 4:30 p.m. Eastern Time20 Oct
  • Is Transcat Inc (TRNS) a Bargain After 3.0% Drop? GF Value Says Undervalued23 Sep
  • Transcat Holdings: Recent Share Price Weakness Provides A Solid Entry Point16 Sep
  • Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical31 Aug
  • Transcat to Participate in Jefferies, Lake Street and D.A. Davidson Investor Conferences in September27 Aug
  • Dimensional Fund Advisors LP Grows Position in Transcat, Inc. $TRNS8 Aug
  • Transcat, Inc. (TRNS) Q1 2027 Earnings Call Transcript5 Aug
  • Transcat Q1 Earnings Call Highlights4 Aug
  • Transcat, Inc. (TRNS) Q1 Earnings and Revenues Top Estimates4 Aug
  • Transcat Reports Strong Fiscal First Quarter 2027 Financial Results with Double-Digit Service Organic Revenue* Growth and Service Gross Margin Expansion4 Aug

Mentions in Filings

  • … s also served as Executive Chairman since August 2023. Prior to his appointment as President and Chief Executive Officer of Lakeland, Mr. Jenkins was the General Counsel and Vice President of Corporate Development for <strong>Transcat, Inc.</strong> (Nasdaq: TRNS), a provider of calibration, repair, inspection and laboratory services, where he served as Transcat’s chief risk officer and advised management and the board of directors over matters of corporate gover …
    BirchBioMed Inc.Transcat Inc·S-1/A - Registration statement (general form, amendment)·Q4 26·9 Oct
  • #\*Titan International, Inc. 195,756 1,867,512 \*Titan Machinery, Inc. 75,804 1,233,331 Toro Co. (The) 207,339 18,971,519 \*<strong>Transcat</strong>, Inc. 27,596 1,664,315 \*Trex Co., Inc. 265,532 10,998,335 TriNet Group, Inc. 126,724 7,760,578 Trinity Industries, Inc. 287,475 8,262,031 \*TrueBlue, Inc. 96,809 518,896
    Dimensional ETF TrustTranscat Inc·NPORT-EX - NT NPORT-P - Notification of late filing (portfolio holdings)·Q1 26·13 Aug
  • … s also served as Executive Chairman since August 2023. Prior to his appointment as President and Chief Executive Officer of Lakeland, Mr. Jenkins was the General Counsel and Vice President of Corporate Development for <strong>Transcat, Inc.</strong> (Nasdaq: TRNS), a provider of calibration, repair, inspection and laboratory services, where he served as Transcat’s chief risk officer and advised management and the board of directors over matters of corporate gover …
    BirchBioMed Inc.Transcat Inc·S-1 - Registration statement (general form)·Q3 26·12 Aug
  • … ties. 1.Ameresco, Inc. 2.Columbus McKinnon Corporation 3.Concrete Pumping Holdings, Inc. 4.Custom Truck One Source, Inc. 5.Energy Recovery, Inc. 6.Enerpac Tool Group Corp. 7.Global Industrial Company 8.Insteel Industries Inc. 9.Karat Packaging Inc. 10.Limbach Holdings, Inc. 11.Matrix Service Company 12.McGrath RentCorp 13.Myers Industries, Inc. 14.Standex International Corporation 15.<strong>Transcat, Inc.</strong> 16.WillScot Holdings Corporation
    NPK International Inc.Transcat Inc·EX-10.2 - 10-Q - Quarterly report Q2·Q2 26·30 Jul
  • … s also served as Executive Chairman since August 2023. Prior to his appointment as President and Chief Executive Officer of Lakeland, Mr. Jenkins was the General Counsel and Vice President of Corporate Development for <strong>Transcat, Inc.</strong> (Nasdaq: TRNS), a provider of calibration, repair, inspection and laboratory services, where he served as Transcat’s chief risk officer and advised management and the board of directors over matters of corporate gover …
    BirchBioMed Inc.Transcat Inc·DRS/A - Draft registration statement (amendment)·Q3 26·1 Jul
  • … oceeds and meaningfully strengthening the Company's balance sheet. • Appointed Lee D. Rudow to its Board of Directors, effective April 9, 2026. Mr. Rudow previously served as Chief Executive Officer of Nasdaq-listed <strong>Transcat, Inc.</strong> --- Fiscal 2027 First Quarter Financial Highlights • Net sales were $47.4 million in Q1 FY27, compared to $46.7 million in Q1 FY26, an increase of $0.7 million or 1.4%, driven by the Fire Service product line and …
    LAKELAND INDUSTRIES INCTranscat Inc·EX-99.1 - 8-K - Results of Operations and Financial Condition·Q2 27·9 Jun

Key Stats

Trading

Px/Chg 1D$90.39 / +0.23%
Avg Volume155.82K
Beta0.90
Mkt Cap846.03M
FD Mkt Cap798.20M

Float

Shrs Out/Float9.36M / 9.14M
Short Float0.06%
Days to Cover2.87
Stock Repurchased$469.00K

Current Valuation

EV969.98M
EV/EBITDA23.90
EV/Sales2.92
P/B2.81
P/S2.54
FCF Yield0.31%
ROE1.79%
ROA1.12%
Current Ratio2.33

Estimates

P/E128.60
Est P/E0.00
Est EPS0.51
Est PEG0.00

Valuation

Metric5Yr AvgAug '22Aug '23Aug '24Aug '25Oct '26
PRICE-BASED RATIOS
Price / Earnings131.1044.6761.8266.6447.86434.53
Price / Sales4.162.482.873.502.509.47
Price / Book Value4.365.906.634.042.422.81
Price / Free Cash Flow111.3868.0887.6647.0326.94327.16
ENTERPRISE VALUE METRICS
Enterprise Value784.1564.6723.6911.3751.0970.0
Enterprise Value / Sales4.592.753.143.512.7010.86
Enterprise Value / EBITDA36.7823.9626.9426.9519.9286.14
Enterprise Value / EBIT78.7940.3345.5044.9539.27223.91

Financials

Full Financials
Millions USD5Yr CAGR (%)Mar '22Mar '23Mar '24Mar '25Mar '26
INCOME STATEMENT
Revenue12.8%205.0230.6259.5278.4331.9
Gross Income16.7%58.468.483.889.5108.3
EBITDA13.2%23.626.933.837.738.8
EBIT-2.6%14.015.920.319.112.6
Net Income-17.1%11.410.713.614.55.4
EPS (Diluted)-21.5%1.501.401.631.570.57
BALANCE SHEET
Cash & ST Inv37.2%1.41.535.21.54.9
Total Assets28.2%177.8195.7287.6385.2480.5
Total Liabilities18.4%91.696.162.498.4179.9
Total Shareholder Equity36.7%86.299.6225.2286.9300.6
CASH FLOW
Net Operating Cash Flow18.6%17.617.032.639.034.9
Cap Ex10.8%-10.2-9.4-13.3-13.2-15.3
Free Cash Flow27.2%7.57.519.325.819.6

Enterprise Value Bridge

Millions USD23 Oct '26
Price (As of 23 Oct '26)81.92
Basic Shares9.36
Market Cap766.8
Diluted Shares9.00
Fully Diluted Shares Outstanding9.00
Fully Diluted Market Cap737.3
+Consolidated Debt128.9
−In-the-Money Convertible Debt—
+Capital Leases29.0
+Operating Leases—
−Cash & Equivalents-4.9
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value890.7

Segment data

Revenue

by Products and services

  • Service65%
  • Distribution Service35%

Revenue

by Geography

  • United States95%
  • Canada5%

Related companies

Danaher Corp /DE/

DHR US

Teradyne, Inc

TER US

Keysight Technologies Inc.

KEYS US

Ametek Inc/

AME US

Compagnie De Saint Gobain

CODYY US

Roper Technologies Inc

ROP US

UltraTech Cement Ltd

UTCEM IB

China Jushi Co., Ltd.

600176 CG

Veralto Corp

VLTO US

Kingspan Group plc

KGSPY US

Mks Inc

MKSI US

Fortive Corp

FTV US